MDP-25
FDA Panel: Long-Used Osteoporosis Drug Too Risky »
"March 7, 2013 -- An FDA panel voted to stop recommending calcitonin salmon for the treatment of osteoporosis in women who are at least five years past menopause.
The committee voted 12-9 against continued marketing of the drug, citing"...
Read the FDA Panel: Long-Used Osteoporosis Drug Too Risky article »
MDP-25
PATIENT INFORMATION
No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.
Last reviewed on RxList: 12/8/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional MDP-25 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Healthy Bones
Get tips and advances in treatment.
Updated & New
